11
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Abnormal regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with normal magnetic resonance imaging findings

, , , &
Pages 89-93 | Published online: 12 Jul 2009

References

  • Harris EN. Syndrome of the black swan. Br J Rheumatol 1987;26:324 —7.
  • Harris N. Antiphospholipid syndrome. In: Klippel JH, Dieppe P, eds. Rheumatology. St. Louis; Mosby. 1994:6: 32.1–32.6.
  • Goel N. Antiphospholipid antibody syndrome: current con-cepts. Hosp Pract 1998;15:129–49.
  • Petri M. Pathogenesis and treatment of the antiphospholipid antibody syndrome. Med Clin N Am 1997;81:151–77.
  • Rosenbaum RB, Campbell SM, Rosenbaum JT. The primary anti-phospholipid antibody syndrome. In: Rosenbaum RB, Campbell SM, Rosenbaum JT, eds. Clinical neurology of rheumatic diseases. Newton; Butterworth-Heinemann. 1996:219–23.
  • Weingarten K, Filippi C, Barbut D, Zimmerman RD. The neuroimaging features of the cardiolipin antibody syndrome. Clin Imaging 1997;21:6–12.
  • Cervera R, Asherson RA, Font J, et al. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunol-ogic characteristics of 50 patients from our clinics and the recent literature. Med Baltimore 1997;76: 203–12.
  • Macucci M, Dotti MT, Battistini S, et al. Primary antiphospho-lipid syndrome: two case reports, one with histological exam-ination of skin, peripheral nerve and muscle. Acta Neurol Napoli 1994;16:87–96.
  • Angelini L, Rumi V, Nardocci N, Combi ML, Bruzzone MG, Pellegrini G. Hemidystonia symptomatic of primary antiphos-pholipid syndrome in childhood. Mov Disord 1993;8:383–6.
  • Molad Y, Sidi Y, Gornish M, Lerner M, Pinkhas J, Weinberger A. Lupus anticoagulant: correlation with magnetic resonance imaging of brain lesions. J Rheumatol 1992;19:556–61.
  • Kao CH, Lan JL, Hsieh JF, et al. Evaluation of regional cerebral blood flow with Tc-99m-HMPAO in primary antipho-pholipid antibody syndrome. J Nucl Med 1999;40:1446–50.
  • Neirinckx R, Canning L, Piper I, et al. Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 1987;28:191–202.
  • Juni JE, Waxman AD, Devous MD, et al. Procedure guildline for brain perfusion SPECT using technetium-99m radio-pharmaceuticals. Society of Nuclear Medicine. J Nucl Med 1998;39:923–6.
  • Leveille J, Demonceau G, De Roo M, et al. Characterization of Tc-99m-L,L-ECD for brain perfusion. Part 2. Biodistribution and brain imaging in humans. J Nucl Med 1989;30:1902–10.
  • Tokumaru S, Yoshikai T, Uchino A, Matsui M, Kuroda Y, Kudo S. Technetium-99m-ECD SPECT in antiphospholipid antibody syndrome: a drastic improvement in brain perfusion by antiplatelet therapy. Eur Radiol 2001;11:2611–5.
  • Asenbaum S, Brucke T, Pirker W, Pietrzyk U, Podreka I. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison. J Nucl Med 1998;39: 613–8.
  • Koyama M, Kawashima R, Ito H, et al. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. J Nucl Med 1997;38:587–92.
  • van Dyck CH, Lin CH, Smith EO, et al. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzehimer's disease. J Nucl Med 1996;37:1749–55.
  • Leveille J, Demonceau G, Walovitch RC. Intrasubject compar-ison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. J Nucl Med 1992;33: 480–4.
  • Berrouschot J, Barthel H, von Kummer R, Knapp WH, Hesse S, Schneider D. 99m technetium-ethyl-cysteinate-dimer single-photon emission CT can predict fatal ischemic brain edema. Stroke 1998;29:2556–62.
  • Brass LM, Walovitch RC, Joseph JL, et al. The role of single photon emission computed tomography brain imaging with 99mTc-bicisate in the localization and definition of mechanism of ischemic stroke. J Cereb Blood Flow Metab 1994;14 Suppl 1:S91–8.
  • Szpak GM, Kuczynska-Zardzewialy A, Popow J. Brain vascu-lar changes in the case of primary antiphospholipid syndrome. Folia Neuropathol 1996;34:92–6.
  • Hughson MD, McCarty GA, Sholer CM, Brumback RA. Thrombotic cerebral arteriopathy in patients with the antiphos-pholipid syndrome. Mod Pathol 1993;6:644–53.
  • Westerman EM, Miles JM, Backonja M, Sundstrom WR. Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Evidence for endothelial injury as the primary event. Arthritis Rheum 1992;35:1038–41.
  • Kao CH, Ho YJ, Lan JL, ChangLai SP, Liao KK, Chieng PU. Discrepancy between regional cerebral blood flow and glucose metabolism of brain in SLE patients. Arthritis Rheum 1999;42:61–8.
  • Kao CH, Ho YJ, Lan JL, ChangLai SP, Chieng PU. Regional cerebral blood flow and glucose metabolism in Sjogren's syndrome. J Nucl Med 1998;39:1354–6.
  • Kao CH, Lan JL, ChangLai SP, Chieng PU. Tc-99m HMPAO SPECT and MRI of brain in neuro-Behcef s patients. J Nucl Med 1998;39:1707–10.
  • Kao CH, Lan JL, ChangLai SP, Chieng PU. Tc-99m HMPAO brain SPECT in Sjogren's syndrome patients. J Nucl Med 1998;39:773–7.
  • Hughes RAC. Pathogenesis of neurological involvement in SLE. Lancet 1994;343:580–1.
  • Balada E, Ordi-Ros J, Parades F, Villarreal J, Mauri M, Vilardell-Tarres M. Antiphosphatidylethanolamine antibodies contribute to the diagnosis of antiphospholipid syndrome in patients with systemic lupus erythematosus. Scand J. Rheumatol 2001;30:235–41.
  • Vaidya S, Logan JW. Anti-cardiolipin antibodies, Raynaud's phenomenon with digital ischemia, and non small cell carcin-oma of the lung. Scand J Rheumatol 2001;30:172–4.
  • Bick RL, Baker WF Jr. The antiphospholipid and thrombosis syndromes. Med Clin North Am 1994;78:667–84.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.